Results 251 to 260 of about 712,965 (355)

Revisores

Revista Brasileira de Horticultura Ornamental, 2013
openaire   +3 more sources

Assessing a Mitochondrial Disease Treatment via a Novel Statistical Technique for Accelerometer Data

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Therapeutic development for mitochondrial diseases, rare genetic disorders with pathogenic defects of oxidative phosphorylation, is hindered by unsatisfactory outcome measures. To address this problem, we provide the first clinical application of a novel, bias‐adjusted outcome measure of acceleration across a range of subjects ...
Ian W. McKeague, Kristin Engelstad, Yue Ge, Amber Tucker, Shufang Li, Jasim Uddin, Ziwei Zhao, John L. P. Thompson, Michio Hirano   +8 more
wiley   +1 more source

Hormone therapy and cancer risks in transgender people: a systematic review. [PDF]

Epidemiol Serv Saude
Uchimura LYT, Yonekura T, Figueiró MF, Quintans JR, Freire P, Maia FHA.   +5 more
europepmc   +1 more source

VIII.—Revised Nomenclature of the Species described in Bate and Westwood's ‘British Sessile-eyed Crustacea’ [PDF]

, 1905
Canon A.M. Norman
openalex   +1 more source

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

Blood, 2016
J. Emile, O. Abla, S. Fraitag, A. Horne, J. Haroche, J. Donadieu, L. Requena-Caballero, M. Jordan, O. Abdel-Wahab, C. Allen, F. Charlotte, E. Diamond, R. Egeler, A. Fischer, Juana Gil Herrera, J. Henter, F. Janku, M. Merad, J. Picarsic, C. Rodríguez-Galindo, B. Rollins, A. Tazi, R. Vassallo, L. Weiss   +23 more
semanticscholar   +1 more source

CSF Mitochondrial DNA: Biomarker of Body Composition and Energy Metabolism in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cerebrospinal fluid (CSF) cell‐free mitochondrial DNA (cf‐mtDNA) is a potential biomarker for Parkinson's disease (PD), but its clinical relevance remains unclear. We investigated associations between CSF cf‐mtDNA levels, body composition, nutritional status, and metabolic biomarkers in PD. Methods CSF cf‐mtDNA levels, defined as the
Yasuaki Mizutani, Tsuyoshi Nakai, Yasuhiro Maeda, Reiko Ohdake, Atsuhiro Higashi, Toshiki Maeda, Ryunosuke Nagao, Sayuri Shima, Kazuya Kawabata, Akihiro Ueda, Mizuki Ito, Hirohisa Watanabe   +11 more
wiley   +1 more source

Evidence syntheses to support decision-making related to the Covid-19 pandemic. [PDF]

Rev Saude Publica
Andrade KRC, Carvalho VKDS, Silva RB, Luquine Junior CD, Farinasso CM, Oliveira CF, Mascarenhas F, Paula GAR, Toledo IP, Marinho MAM, Wachira VK, Siqueira ASE, Araújo DV, Sachetti CG, Rêgo DF.   +14 more
europepmc   +1 more source

A Revised List of Japanese Mycetozoa

, 1913
Kayoko Minakata
openalex   +2 more sources

Review af mellembalance ved udlodning af aconto udbytte. [PDF]

, 2005
Lie, Carsten
core  

Nerve Excitability in Asymptomatic Carriers and Amyotrophic Lateral Sclerosis Patients With C9orf72

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We investigated the effects of C9orf72 mutation carriership on peripheral nerve excitability in asymptomatic individuals from families with a history of C9orf72 amyotrophic lateral sclerosis (ALS) and patients. Methods We included 47 asymptomatic individuals from families with a history of C9orf72 ALS, of whom 23 were carriers (C9 ...
Diederik J. L. Stikvoort García, H. Stephan Goedee, Leonard H. van den Berg, Boudewijn T. H. M. Sleutjes   +3 more
wiley   +1 more source